European shares inch higher with focus on UK M&A, Credit Suisse slips

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)

Jan 17 (Reuters) - European stocks edged higher on Monday, with deal talks related to British consumer companies boosting the bluechip FTSE 100, while shares in Credit Suisse slipped after the Swiss bank's chairman quit following an internal probe into his personal conduct.

The pan-European STOXX 600 index .STOXX rose 0.2% by 0806 GMT, with Asian markets choppy after China's central bank cut some key lending rates after mixed economic data, while a U.S. holiday made for thin trading.

China-exposed miners .SXPP and healthcare .SXPP stocks were the top sectoral gainers in Europe, up about 0.8% each.

Lifting UK's FTSE 100 .FTSE , GlaxoSmithKline GSK.L jumped 5.2% after it confirmed over the weekend that it had rejected Unilever's ULVR.L 50-billion-pound offer for its consumer healthcare business.

Unilever slid 5.2% after it signalled on Monday it would pursue the deal, calling it a "strong strategic fit".

Credit Suisse CSGN.S slipped 1.1% after Chairman Antonio Horta-Osorio quit following an internal probe into his personal conduct, including breaches of COVID-19 rules.
Reporting by Sruthi Shankar in Bengaluru; Editing by Shounak Dasgupta

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.